Back

Introduction

31 August 2019 (15:30 - 15:35)
Organised by:
Congress Presentation Part of: Epigenetics: a new pathway to tackle residual risk? Risk Factors and Prevention, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Challenges in targeting residual risk in diabetic patients, post ACS
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Discussion
Professor U. Landmesser (Berlin, DE) Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Epigenetics: a new pathway to tackle residual risk?

The Event

Event poster

ESC Congress 2019

31 August 2019 15:30 CET
You may be interested in
thumbnail
Congress Session
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
31 August 2025
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
Welcome & introduction
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources